Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | LPL | P06858 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.38 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.38 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.38 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL235602 | 0.87 | NR1I2 (0.43) | NR1I2HPGD | |
| SCHEMBL7902561 | 0.84 | NR1I2 (0.42) | NR1I2HPGD | |
| SCHEMBL15445504 | 0.82 | ACHE (0.47) | ACHETDP1ALDH1A1LMNACA2 | |
| SCHEMBL1054613 | 0.81 | ACHE (0.53) | ACHETDP1ALDH1A1LMNACA2 | |
| SCHEMBL11979357 | 0.79 | NR1H2 (0.46) | ACHENR1I2HPGDGAA | |
| SCHEMBL1686889 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1LMNACA2 | |
| SCHEMBL29086820 | 0.79 | NR1I2 (0.39) | NR1I2HPGD | |
| SCHEMBL7862066 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1LMNACA2 | |
| SCHEMBL29242328 | 0.79 | ESR1 (0.50) | NR1I2HPGD | |
| SCHEMBL1686464 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1LMNACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203077-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | NATIONAL SCIENCE FOUNDATION | 2023-06-29 | — | — | US | disclosed |
| US-20230102728-A1 | METHOD OF PREPARING SILANOLS WITH SELECTIVE CYTOCHROME P450 VARIANTS AND RELATED COMPOUNDS AND COMPOSITIONS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2023-03-30 | — | — | US | disclosed |
| US-10723845-B2 | Process for preparing linear carbosiloxane polymers | DOW SILICONES CORPORATION (US) | 2020-07-28 | — | — | US | disclosed |
| US-20200079911-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING EUROPE S.A. | 2020-03-12 | — | — | US | disclosed |
| EP-3153540-B1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING (US) | 2018-06-06 | — | — | EP | disclosed |
| US-20170305948-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | UNIV YALE (US) | 2017-10-26 | — | — | US | disclosed |
| WO-2017062091-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING CORPORATION (US) | 2017-04-13 | — | — | WO | disclosed |
| EP-3153540-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | Dow Corning Corporation (US) | 2017-04-12 | — | — | EP | disclosed |
| EP-2128897-B1 | SILICON DIELECTRIC TREATING AGENT FOR USE AFTER ETCHING, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJITSU LTD (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8716209-B2 | Agent for post-etch treatment of silicon dielectric film, method of manufacturing semiconductor device, and semiconductor device | FUJITSU LIMITED (JP) | 2014-05-06 | — | — | US | disclosed |
| US-20090192265-A1 | Curable composition | KANEKA CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-7511102-B2 | Polymer and liquid gasket for In-Place forming | KANEKA CORPORATION (JP) | 2009-03-31 | — | — | US | disclosed |
| US-20080177001-A1 | CURABLE COMPOSITIONS | KANEKA CORPORATION (JP) | 2008-07-24 | — | — | US | disclosed |
| US-7388038-B2 | Curable compositions | KANEKA CORPORATION (JP) | 2008-06-17 | — | — | US | disclosed |
| US-20070276066-A1 | Curing Composition | KANEKA CORPORATION (JP) | 2007-11-29 | — | — | US | disclosed |
| US-20070225436-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070213459-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070167583-A1 | Curable composition | KANEKA CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| US-20070161732-A1 | Novel polymer and liquid gasket for In-Place forming | KANEKA CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| US-7186780-B2 | Polymer and liquid gasket for in-place forming | KANEKA CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230102728-A1 | METHOD OF PREPARING SILANOLS WITH SELECTIVE CYTOCHROME P450 VARIANTS AND RELATED COMPOUNDS AND COMPOSITIONS | CYP2E1, POR, CYP3A43 | ACHE 2878/4885TDP1 2684/4885NR1I2 511/4885 |
| US-20230203077-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | TIMCC, YAP1, TET2 | ACHE 814/4885TDP1 2408/4885NR1I2 4809/4885 |
| US-20170305948-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | TIMCC, YAP1, TET2 | ACHE 814/4885TDP1 2408/4885NR1I2 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.